WP
CELG

WealthSource Partners’s Celgene Corp CELG Stock Holding History

WealthSource Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,718
Closed -$568K – 468
2019
Q3 		$568K Sell
5,718
-197
-3% -$18.7K 0.09% 216
2019
Q2 		$547K Buy
5,915
+1,293
+28% +$123K 0.09% 222
2019
Q1 		$436K Sell
4,622
-358
-7% -$31.3K 0.1% 193
2018
Q4 		$319K Buy
4,980
+2,337
+88% +$173K 0.09% 201
2018
Q3 		$237K Sell
2,643
-534
-17% -$47.2K 0.06% 264
2018
Q2 		$252K Buy
3,177
+44
+1% +$3.65K 0.07% 235
2018
Q1 		$279K Sell
3,133
-42
-1% -$4.03K 0.08% 216
2017
Q4 		$331K Sell
3,175
-3,025
-49% -$341K 0.1% 186
2017
Q3 		$904K Buy
6,200
+375
+6% +$51.1K 0.3% 83
2017
Q2 		$756K Buy
5,825
+158
+3% +$19.4K 0.26% 96
2017
Q1 		$705K Buy
+5,667
New +$678K 0.26% 95

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

WealthSource Partners's CELG Position: Q4 2019 in Review

WealthSource Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,718 shares — an estimated $568K sold.

WealthSource Partners first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $904K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • WealthSource Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • WealthSource Partners sold 5,718 Celgene Corp shares in Q4 2019, an estimated $568K.
  • WealthSource Partners first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • WealthSource Partners's Celgene Corp position peaked at $904K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on WealthSource Partners's 13F filing for Q4 2019, filed 12 Feb 2020.